)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Bioretec
Bioretec (BRETEC) investor relations material
Bioretec Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary13 Feb, 2026
Executive summary
2025 was a foundational rebuilding year with major C-suite changes, five new management team members, and a strategic shift to direct U.S. distribution, resulting in a more agile organization and improved commercial focus.
Achieved significant regulatory milestones, including a third Breakthrough Device Designation for RemeOs DrillPin, CE mark approval, and CMS Transitional Pass-Through Payment for RemeOs Trauma Screw.
Enhanced commercial strategy with direct sales growth, expanded KOL program, and new distribution partners in key global markets, with commercial momentum increasing in key markets.
Updated strategic priorities focus on commercial leadership, innovation, and evidence generation for breakthrough products.
New product launches are planned to further strengthen the portfolio.
Financial highlights
Net sales for 2025 were EUR 3,522 thousand, down 22.5% year-over-year, with H2 net sales falling 41.7%.
2025 revenue was slightly below 2024, reflecting transition impacts and a shift from the old distribution model; 2024 revenue included €0.9 million from the previous distribution model.
EBITDA for 2025 was EUR -8,476 thousand, with a net loss of EUR -9,483 thousand, both significantly worse than 2024.
One-off items in 2025 included €1.1 million related to unrepurchased inventory.
R&D expenditure rose to 85.8% of net sales, reflecting heavy investment in product development.
Outlook and guidance
New financial targets for 2026-2028: net sales exceeding EUR 10 million by 2028 and average sales margin above 70%.
No annual guidance for 2026 is provided; focus remains on commercial growth and execution.
No expectation of cash flow positivity or profitability during the strategy period due to ongoing R&D and commercialization investments.
2028 targets do not include potential acceleration from business development or partnerships.
The Board proposes no dividend for 2025.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bioretec earnings date
Q1 202614 May, 2026
Bioretec
Next Bioretec earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bioretec Oy is a medical device manufacturer based in Finland, specializing in the development, manufacturing, and commercialization of bioresorbable orthopedic implants and implant materials. These products are designed for the treatment of bone and soft tissue injuries and are utilized in various surgical applications, including pediatrics, trauma surgery, and sports surgery. The company's Activa product line includes bioabsorbable biopolymer products. Bioretec Oy also has a subsidiary in Germany, BRI.Tech GmbH, and its products are used globally. The company is headquartered in Finland, and its shares are listed on the Nasdaq Helsinki.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage